There Is a Close Association between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study Tomoe Kinoshita Masashi Shimoda Junpei Sanada Yoshiro Fushimi Yurie Hirata Shintaro Irie Atsushi Obata Tomohiko Kimura Hidenori Hirukawa Kenji Kohara Fuminori Tatsumi Shinji Kamei Shuhei Nakanishi Tomoatsu Mune Kohei Kaku Hideaki Kaneto 10.6084/m9.figshare.6270008.v1 https://adisjournals.figshare.com/articles/figure/There_Is_a_Close_Association_between_the_Recovery_of_Liver_Injury_and_Glycemic_Control_after_SGLT2_Inhibitor_Treatment_in_Japanese_Subjects_with_Type_2_Diabetes_A_Retrospective_Clinical_Study/6270008 <p></p><p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-018-0447-8"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p><br><p></p> 2018-06-18 15:45:57 Liver injury SGLT2 inhibitor Type 2 diabetes mellitus